- Home
- EBS vs HPI Comparison
EBS vs HPI Comparison
Compare EBS & HPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBS
- HPI
- Stock Information
- Founded
- EBS 1998
- HPI 2002
- Country
- EBS United States
- HPI United States
- Employees
- EBS N/A
- HPI N/A
- Industry
- EBS Biotechnology: Pharmaceutical Preparations
- HPI Trusts Except Educational Religious and Charitable
- Sector
- EBS Health Care
- HPI Finance
- Exchange
- EBS Nasdaq
- HPI Nasdaq
- Market Cap
- EBS 359.3M
- HPI 426.7M
- IPO Year
- EBS 2006
- HPI N/A
- Fundamental
- Price
- EBS $9.23
- HPI $16.15
- Analyst Decision
- EBS Strong Buy
- HPI
- Analyst Count
- EBS 3
- HPI 0
- Target Price
- EBS $14.33
- HPI N/A
- AVG Volume (30 Days)
- EBS 1.5M
- HPI 64.7K
- Earning Date
- EBS 08-06-2025
- HPI 01-01-0001
- Dividend Yield
- EBS N/A
- HPI 8.97%
- EPS Growth
- EBS N/A
- HPI N/A
- EPS
- EBS 2.53
- HPI N/A
- Revenue
- EBS $851,600,000.00
- HPI N/A
- Revenue This Year
- EBS N/A
- HPI N/A
- Revenue Next Year
- EBS $14.20
- HPI N/A
- P/E Ratio
- EBS $3.65
- HPI N/A
- Revenue Growth
- EBS N/A
- HPI N/A
- 52 Week Low
- EBS $4.02
- HPI $12.85
- 52 Week High
- EBS $12.73
- HPI $16.83
- Technical
- Relative Strength Index (RSI)
- EBS 68.42
- HPI 62.39
- Support Level
- EBS $8.91
- HPI $15.92
- Resistance Level
- EBS $9.43
- HPI $16.07
- Average True Range (ATR)
- EBS 0.59
- HPI 0.10
- MACD
- EBS 0.15
- HPI 0.01
- Stochastic Oscillator
- EBS 88.89
- HPI 94.17
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
About HPI John Hancock Preferred Income Fund of Beneficial Interest
John Hancock Preferred Income Fund is a closed-end, diversified management investment company. Its primary investment objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. It seeks to achieve its investment objectives by investing in securities that may be undervalued relative to similar securities in the marketplace. The fund's principal investment strategies include investing a majority of its assets in preferred stocks and other preferred securities. Its portfolio composition consists of U.S preferred securities, common stocks, foreign preferred securities, corporate bonds, and short-term investments.